Home
/

Heart Failure

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 31, 2026
Last updated
May 30, 2026
Key takeaway:

Blood testing for heart failure tracks albumin (3.5–5.0 g/dL), sodium (135–145 mEq/L), creatinine (0.6–1.3 mg/dL), and hs-CRP (ideally <1 mg/L)—four markers that together reveal fluid overload, kidney-cardiac crosstalk, malnutrition, and inflammation driving systemic strain beyond the failing pump. Low sodium signals water retention and neurohormonal activation in advanced disease, while rising creatinine may limit diuretic adjustments; abnormal patterns are associated with higher hospitalization and mortality risk.

Read more →
Table of contents

Heart Failure and the Whole-Body Biomarker Footprint

Heart failure biomarkers are molecules your body releases when the heart is under strain, injured, or remodeling. They translate what the heart is feeling—pressure, stretch, fluid overload, and tissue stress—into measurable signals in the blood. The most central are hormones made by heart muscle when it is overfilled or stretched (natriuretic peptides: BNP, NT‑proBNP). These reflect congestion and help distinguish heart-related breathlessness from lung or other causes. Markers of heart cell injury (cardiac troponins) capture ongoing damage even when symptoms are subtle. Signals linked to scarring and inflammation (fibrosis and stress markers such as sST2 and galectin‑3) hint at how the heart’s structure is changing over time. Together, these biomarkers let clinicians detect heart failure earlier, judge its biological burden, tailor therapy, and track whether treatment is relieving strain on the heart. In short, they turn invisible heart stress into actionable information, guiding decisions when exam findings are unclear and helping forecast clinical risk (prognosis) as the condition evolves.

Why Routine Chemistry Matters in a Cardiac Syndrome

Heart failure is a whole‑body syndrome, not just a weak pump. Blood biomarkers translate congestion, perfusion, and inflammation into objective signals from the kidneys, liver, vasculature, and immune system. Tracking them helps explain symptoms like breathlessness, swelling, fatigue, and mental fog, and reveals risk before complications emerge.Albumin is typically about 3.5–5, sodium 135–145, creatinine roughly 0.6–1.3 (lower in women and older adults), and hs‑CRP ideally under 1 (1–3 average, above 3 elevated). In general, albumin is healthiest in the mid‑to‑high range, sodium near the middle, creatinine toward the lower end appropriate for body size/sex, and hs‑CRP as low as possible. High creatinine points to reduced kidney filtration from low cardiac output or renal congestion; high hs‑CRP flags inflammation or infection that can destabilize heart failure. High sodium is less common and often reflects dehydration; unusually high albumin usually indicates hemoconcentration.When these values run low, they tell an important story. Low albumin reflects inflammation, poor nutrition, or liver congestion, and it worsens edema, ascites, frailty, and slow healing. Low sodium signals excess water retention and neurohormonal activation; people may feel fatigue, cramps, confusion, or even seizures, and it often marks more advanced heart failure. Very low creatinine often means low muscle mass—more common in women and older adults—so kidney injury can be masked; it can travel with frailty. Low hs‑CRP is reassuring.Big picture: these markers knit together the heart–kidney–liver–immune axis. Abnormal patterns correlate with hospitalizations, cognitive effects, and survival. Regular blood testing anchors diagnosis, risk stratification, and monitoring as the circulatory, renal, and inflammatory systems adapt over time.

What General Bloodwork Can and Can't Say About the Heart

Heart failure blood testing provides a window into how well your body’s vital systems are coping with the demands of circulation, energy delivery, and fluid balance. When the heart struggles to pump efficiently, it affects not just the cardiovascular system, but also metabolism, kidney function, brain health, and immune response. At Superpower, we focus on four key biomarkers—Albumin, Sodium, Creatinine, and high-sensitivity C-reactive protein (hs-CRP)—to give a comprehensive view of your body’s adaptation to heart failure.Albumin is a major blood protein produced by the liver, reflecting both nutritional status and the body’s ability to maintain fluid balance. Low albumin can signal chronic inflammation or fluid overload, both common in heart failure. Sodium is an essential electrolyte that helps regulate blood volume and nerve function; abnormal sodium levels often indicate disrupted fluid handling or hormonal changes due to heart failure. Creatinine is a waste product filtered by the kidneys; rising levels suggest reduced kidney function, which often accompanies or worsens heart failure. hs-CRP is a marker of inflammation, and higher levels can point to ongoing stress or injury within the cardiovascular system.Together, these biomarkers help assess the stability of your body’s internal environment. Balanced albumin and sodium support steady blood pressure and tissue health, while normal creatinine indicates the kidneys are keeping up with metabolic demands. A low hs-CRP suggests minimal inflammation, supporting resilience and recovery.Interpretation of these results depends on factors like age, sex, recent illness, medications, and even laboratory methods. For example, older adults or those with chronic conditions may have different “normal” ranges, and certain drugs can alter these markers independently of heart function.

FAQs

Heart failure blood testing checks how your heart, kidneys, liver, and blood vessels are handling fluid and pressure changes. Superpower tests your blood for albumin (liver-made protein reflecting nutrition, vascular leak, and hepatic function), sodium (electrolyte of fluid balance and neurohormonal stress), creatinine (kidney filtration and renal perfusion), and hs-CRP (high-sensitivity C‑reactive protein for systemic inflammation). Together, these markers reveal congestion, volume status, kidney strain, and inflammatory burden that commonly accompany heart failure.

These labs expose system stress before symptoms escalate. Albumin tracks protein status and vascular leak; sodium uncovers dilutional hyponatremia from neurohormonal activation; creatinine flags reduced renal perfusion; hs-CRP signals inflammatory risk. In combination, they help stage severity, spot complications, and monitor safety. They complement imaging and clinical assessment, providing a baseline and trendline to judge stability or decompensation.

Yes. With Superpower, our team member can organize a blood draw in your home.

Get a baseline, then repeat to track trends. Stable patients are commonly monitored periodically; testing is more frequent during clinical changes or medication adjustments. Trend data over time is more informative than a single value, especially for sodium, creatinine, and hs-CRP.

Hydration status shifts sodium and creatinine. Diuretics, ACE inhibitors, ARBs, and NSAIDs influence sodium and kidney function. Infection, recent strenuous exercise, or vaccination can raise hs-CRP. Malnutrition, liver disease, nephrotic loss, and systemic inflammation lower albumin. Acute illness, bleeding, pregnancy, lab timing, and sample handling can also move results.

No special fasting is usually required. Stay normally hydrated to avoid false shifts in sodium and creatinine. Avoid vigorous exercise for 24 hours so hs-CRP reflects baseline inflammation. Tell the team about recent infections, vaccinations, or new medications, as these can affect results.

References

  1. Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., ... Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure. Journal of Cardiac Failure, 28(5), e1-e167. https://doi.org/10.1016/j.cardfail.2022.02.010
  2. Ibrahim, N., & Januzzi, J. L. (2015). The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Expert Review of Cardiovascular Therapy, 13(9), 1017-1030. https://doi.org/10.1586/14779072.2015.1071664
  3. Oremus, M., McKelvie, R., Don-Wauchope, A., Santaguida, P. L., Ali, U., Balion, C., Hill, S., Booth, R., Brown, J. A., Bustamam, A., Sohel, N., & Raina, P. (2014). A systematic review of BNP and NT-proBNP in the management of heart failure: Overview and methods. Heart Failure Reviews, 19(4), 413-419. https://doi.org/10.1007/s10741-014-9440-0
  4. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG clinical guideline: Evaluation of abnormal liver chemistries. The American Journal of Gastroenterology, 112(1), 18-35. https://doi.org/10.1038/ajg.2016.517
  5. Mayo Clinic. (n.d.). Heart failure - Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey